273 related articles for article (PubMed ID: 23064365)
1. Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis.
Koliaraki V; Roulis M; Kollias G
J Clin Invest; 2012 Nov; 122(11):4231-42. PubMed ID: 23064365
[TBL] [Abstract][Full Text] [Related]
2. Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis.
Roulis M; Nikolaou C; Kotsaki E; Kaffe E; Karagianni N; Koliaraki V; Salpea K; Ragoussis J; Aidinis V; Martini E; Becker C; Herschman HR; Vetrano S; Danese S; Kollias G
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):E4658-67. PubMed ID: 25316791
[TBL] [Abstract][Full Text] [Related]
3. ABIN2 Function Is Required To Suppress DSS-Induced Colitis by a Tpl2-Independent Mechanism.
Nanda SK; Nagamori T; Windheim M; Amu S; Aviello G; Patterson-Kane J; Arthur JSC; Ley SC; Fallon P; Cohen P
J Immunol; 2018 Dec; 201(11):3373-3382. PubMed ID: 30355787
[TBL] [Abstract][Full Text] [Related]
4. Tenascin-C Produced by Intestinal Myofibroblasts Promotes Colitis-associated Cancer Development Through Angiogenesis.
Kawamura T; Yamamoto M; Suzuki K; Suzuki Y; Kamishima M; Sakata M; Kurachi K; Setoh M; Konno H; Takeuchi H
Inflamm Bowel Dis; 2019 Mar; 25(4):732-741. PubMed ID: 30517646
[TBL] [Abstract][Full Text] [Related]
5. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
6. BMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3.
Liu X; Wei W; Li X; Shen P; Ju D; Wang Z; Zhang R; Yang F; Chen C; Cao K; Zhu G; Chen H; Chen L; Sui J; Zhang E; Wu K; Wang F; Zhao L; Xi R
Gastroenterology; 2017 Dec; 153(6):1607-1620. PubMed ID: 28780076
[TBL] [Abstract][Full Text] [Related]
7. Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretion.
Shaker A; Swietlicki EA; Wang L; Jiang S; Onal B; Bala S; DeSchryver K; Newberry R; Levin MS; Rubin DC
J Clin Invest; 2010 Jun; 120(6):2081-93. PubMed ID: 20458144
[TBL] [Abstract][Full Text] [Related]
8. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M
Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195
[TBL] [Abstract][Full Text] [Related]
9. The B-cell tumor promoter Bcl-3 suppresses inflammation-associated colon tumorigenesis in epithelial cells.
Tang W; Wang H; Ha HL; Tassi I; Bhardwaj R; Claudio E; Siebenlist U
Oncogene; 2016 Dec; 35(48):6203-6211. PubMed ID: 27132515
[TBL] [Abstract][Full Text] [Related]
10. IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis.
Pallangyo CK; Ziegler PK; Greten FR
J Exp Med; 2015 Dec; 212(13):2253-66. PubMed ID: 26621452
[TBL] [Abstract][Full Text] [Related]
11. NPC1L1 knockout protects against colitis-associated tumorigenesis in mice.
He J; Shin H; Wei X; Kadegowda AK; Chen R; Xie SK
BMC Cancer; 2015 Mar; 15():189. PubMed ID: 25881076
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
13. Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation.
Serebrennikova OB; Tsatsanis C; Mao C; Gounaris E; Ren W; Siracusa LD; Eliopoulos AG; Khazaie K; Tsichlis PN
Proc Natl Acad Sci U S A; 2012 May; 109(18):E1082-91. PubMed ID: 22451924
[TBL] [Abstract][Full Text] [Related]
14. Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis.
Decicco-Skinner KL; Trovato EL; Simmons JK; Lepage PK; Wiest JS
Oncogene; 2011 Jan; 30(4):389-97. PubMed ID: 20935675
[TBL] [Abstract][Full Text] [Related]
15. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18.
Salcedo R; Worschech A; Cardone M; Jones Y; Gyulai Z; Dai RM; Wang E; Ma W; Haines D; O'hUigin C; Marincola FM; Trinchieri G
J Exp Med; 2010 Aug; 207(8):1625-36. PubMed ID: 20624890
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
17. Epimorphin deletion inhibits polyposis in the Apcmin/+ mouse model of colon carcinogenesis via decreased myofibroblast HGF secretion.
Swietlicki EA; Bala S; Lu J; Shaker A; Kularatna G; Levin MS; Rubin DC
Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(8):G564-72. PubMed ID: 23886856
[TBL] [Abstract][Full Text] [Related]
18. Mbd2 enables tumourigenesis within the intestine while preventing tumour-promoting inflammation.
May S; Owen H; Phesse TJ; Greenow KR; Jones GR; Blackwood A; Cook PC; Towers C; Gallimore AM; Williams GT; Stürzl M; Britzen-Laurent N; Sansom OJ; MacDonald AS; Bird AP; Clarke AR; Parry L
J Pathol; 2018 Jul; 245(3):270-282. PubMed ID: 29603746
[TBL] [Abstract][Full Text] [Related]
19. Role of milk fat globule-epidermal growth factor 8 in colonic inflammation and carcinogenesis.
Kusunoki R; Ishihara S; Tada Y; Oka A; Sonoyama H; Fukuba N; Oshima N; Moriyama I; Yuki T; Kawashima K; Ansary MM; Tajima Y; Maruyama R; Nabika T; Kinoshita Y
J Gastroenterol; 2015 Aug; 50(8):862-75. PubMed ID: 25596854
[TBL] [Abstract][Full Text] [Related]
20. Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer.
Short SP; Pilat JM; Barrett CW; Reddy VK; Haberman Y; Hendren JR; Marsh BJ; Keating CE; Motley AK; Hill KE; Zemper AE; Washington MK; Shi C; Chen X; Wilson KT; Hyams JS; Denson LA; Burk RF; Rosen MJ; Williams CS
Gastroenterology; 2021 Apr; 160(5):1694-1708.e3. PubMed ID: 33388316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
